Publisher
Springer Science and Business Media LLC
Reference71 articles.
1. Gao, F. et al. Mesenchymal stem cells and immunomodulation: current status and future prospects. Cell Death Dis 7, e2062 (2016).
2. Le Blanc, K. et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet (London, England) 371, 1579–1586 (2008).
3. Sensebe, L., Krampera, M., Schrezenmeier, H., Bourin, P. & Giordano, R. Mesenchymal stem cells for clinical application. Vox sanguinis 98, 93–107 (2010).
4. EMA, E. M. A. Note for guidance on minimizing the risk of transmitting animal spongiform encephalopathy agents via human and veterinary medicinal products. EMEA 410/01 rev. 2 (2008).
5. Horwitz, E. M. et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proceedings of the National Academy of Sciences of the United States of America 99, 8932–8937 (2002).
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献